Publication

A liver secretome gene signature-based approach for determining circulating biomarkers of NAFLD severity

PLoS One 7(10):e0275901, 2022

Hagemann CA, Legart C, Møllerhøj MB, Madsen MR, Hansen HH, Kønig MJ, Helgstrand F, Hjørne FP, Toxværd A, Langhoff JL, Kielgast UL, Gluud LL, Ægidius H, Rigbolt KTG, Vilsbøll T, Jelsing J, Knop FK

Share this page

Resource Library

Related resources
Poster
Preclinical efficacy and clinical translatability of elafibranor in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH 
Open
Publication
Hepatic molecular characteristics of patients with varying degrees of nonalcoholic steatohepatitis compared to healthy normal weight individuals
Open
Publication
Elafibranor and liraglutide improve differentially liver health and metabolism in a mouse model of non-alcoholic steatohepatitis
Open
Publication
Hepatoprotective effects of the long-acting FGF21 analogue PF-05231023 in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH
Open

For further information

Contact us

Gubra

Hørsholm Kongevej 11B
2970 Hørsholm
Denmark

+45 3152 ­2650

Back To Top